Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
atopic dermatitis
Pharma
Lilly's Ebglyss scores eczema trial win in children
With positive results from a phase 3 trial, Eli Lilly is set up to make Ebglyss available to a younger group of eczema patients.
Kevin Dunleavy
Mar 16, 2026 10:50am
Galderma doubles Nemluvio peak sales outlook to $4B-plus
Mar 5, 2026 11:20am
Arcutis adds '90210' star power to skin condition awareness push
Nov 4, 2025 11:00am
Galderma's itch relief claims scratched after Sanofi complaint
Oct 8, 2025 9:45am
Ivonescimab, Fosun-Sitala, Hutchmed—Fierce Pharma Asia
Aug 29, 2025 8:15am
Leo increases sales in US and bumps up 2025 revenue guidance
Aug 19, 2025 12:38pm
